Cargando…

Effect of silymarin on liver size and nonalcoholic fatty liver disease in morbidly obese patients: A randomized double-blind clinical trial

BACKGROUND: A large liver size is a factor that may increase the difficulty of bariatric surgery (BS) and unwanted complications. Some agents have been used to decrease the liver size before BS. Silymarin has been used as an antioxidant agent to improve liver function tests. This study was designed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atarodi, Hamed, Pazouki, Abdolreza, Gholizadeh, Barmak, Karami, Reza, Kabir, Ali, Sadri, Ghazal, Kassir, Radwan, Kermansaravi, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693701/ https://www.ncbi.nlm.nih.gov/pubmed/36438071 http://dx.doi.org/10.4103/jrms.jrms_683_21

Ejemplares similares

Five-year outcomes of one anastomosis gastric bypass as conversional surgery following sleeve gastrectomy for weight loss failure
por: Kermansaravi, Mohammad, et al.
Publicado: (2022)

One-anastomosis gastric bypass as an alternative procedure of choice in morbidly obese patients
por: Solouki, Ali, et al.
Publicado: (2018)

A case of stapled resection of redundant diaphragm and early evisceration of gastrointestinal content
por: Talebian, Pedram, et al.
Publicado: (2018)

Severe hypoalbuminemia and steatohepatitis leading to death in a young vegetarian female, 8 months after mini gastric bypass: A case report
por: Kermansaravi, Mohammad, et al.
Publicado: (2016)

Short-term outcomes of the conversion of one anastomosis gastric bypass to Roux-en-Y gastric bypass in symptomatic reflux patients without revising the size of the gastric pouch
por: Kermansaravi, Mohammad, et al.
Publicado: (2021)

Laparoscopic repair of an incarcerated Morgagni Hernia in a COVID-19-positive patient: A video case report
por: Pazouki, Abdolreza, et al.
Publicado: (2022)

Weight loss after one-anastomosis/mini-gastric bypass – The impact of biliopancreatic limb: A retrospective cohort study
por: Kermansaravi, Mohammad, et al.
Publicado: (2020)

Petersen's Space Internal Hernia after Laparoscopic One Anastomosis (Mini) Gastric Bypass
por: Kermansaravi, Mohammad, et al.
Publicado: (2018)

Bariatric surgery in transplant recipients: A narrative review
por: Kermansaravi, Mohammad, et al.
Publicado: (2021)

Laparoscopic total gastrectomy for a giant gastrointestinal stromal tumor (GIST) with acute massive gastrointestinal bleeding: a case report
por: Kermansaravi, Mohammad, et al.
Publicado: (2017)

Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats
por: Mengesha, Tewodros, et al.
Publicado: (2021)

One anastomosis gastric bypass as a one-stage bariatric surgical procedure in patients with BMI ≥ 50 kg/m(2)
por: Kermansaravi, Mohammad, et al.
Publicado: (2022)

Revisional surgery after one anastomosis/mini gastric bypass: A narrative review
por: Kermansaravi, Mohammad, et al.
Publicado: (2020)

Correction to: Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats
por: Mengesha, Tewodros, et al.
Publicado: (2021)

Small-bowel obstruction after modified jejunoileal bypass surgery due to gallstone ileus
por: Kermansaravi, Mohammad, et al.
Publicado: (2019)

Investigating the impact of silymarin on liver oxidative injury
por: Jamalian, Mohammad, et al.
Publicado: (2020)

Effect of silymarin in diabetes mellitus patients with liver diseases
por: Jose, Manonmani Alvin, et al.
Publicado: (2011)

Silymarin Accelerates Liver Regeneration after Partial Hepatectomy
por: Wu, Jia-Ping, et al.
Publicado: (2015)

A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury
por: Luangchosiri, Chote, et al.
Publicado: (2015)

Retroperitoneal duodenal perforation due to COVID-19: An extremely rare case report
por: Eghbali, Foolad, et al.
Publicado: (2022)

Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2023)

Changes in serum albumin and liver enzymes following three different types of bariatric surgery: six-month follow-up. A retrospective cohort study
por: Zadeh, Mohadeseh Hassan, et al.
Publicado: (2021)

The Effect of Mycotoxins and Silymarin on Liver Lipidome of Mice with Non-Alcoholic Fatty Liver Disease
por: Bechynska, Kamila, et al.
Publicado: (2021)

Retracted: Silymarin Accelerates Liver Regeneration after Partial Hepatectomy
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2017)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
por: Gillessen, Anton, et al.
Publicado: (2020)

Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review
por: Tighe, Sean P., et al.
Publicado: (2020)

Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity
por: Terzi, Funda, et al.
Publicado: (2022)

Protective Effect of Silymarin on Liver in Experimental in the Sepsis Model of Rats
por: Aydemir Celep, Nevra, et al.
Publicado: (2023)

COVID-19 Vaccination and Timing of Bariatric Surgery: Considerations and Concerns for Patients with Severe Obesity
por: Pazouki, Abdolreza, et al.
Publicado: (2021)

The Effect of Green Tea Extract Supplementation on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease
por: Pezeshki, Ali, et al.
Publicado: (2016)

The role of alimentary and biliopancreatic limb length in outcomes of Roux-en-Y gastric bypass
por: Darabi, Sattar, et al.
Publicado: (2019)

Silymarin’s Protective Effects and Possible Mechanisms on Alcoholic Fatty Liver for Rats
por: Zhang, Wei, et al.
Publicado: (2013)

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
por: Federico, Alessandro, et al.
Publicado: (2017)

Silymarin in the management of liver enzyme activity in steatohepatitis: a case report
por: Torre, Aldo
Publicado: (2023)

Optimal dose of silymarin for the management of drug‑induced liver injury in oncology
por: Kohutek, Filip, et al.
Publicado: (2023)

Hepatoprotective effects of silymarin in management of liver injury caused by tuberculosis treatment
por: Lee, Yeong Yeh, et al.
Publicado: (2023)

Impact of Silymarin Supplements on Liver Enzyme Levels: A Systematic Review
por: Calderon Martinez, Ernesto, et al.
Publicado: (2023)

Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3fq5v1adhbfi55j7sdhs7bokaj